Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of this study is to develop and validate a patient-reported-outcome instrument (PROFTC-I: Patient Reported Outcome Financial Toxicity in Cancer - Italy) able to describe and measure financial problems of Italian patients receiving cancer treatment.
The project will be conducted according to the methodology delineated by the International Society for Pharmacoeconomics and Outcome Research (ISPOR) Patient Reported Outcomes Content Validity Good Research Practices Task Force in the following phases: concept elicitation and coding, item generation and analysis, instrument refinement and internal validation, and external validation.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Phase 1: concept elicitation and coding | The aim of this phase is to elicit concepts from patients, caregivers, and oncology clinicians through focus groups of patients and caregivers, qualitative interviews and surveys. Approximately 55 patients or caregivers will participate in this phase. | ||
| Phase 2: Item generation and analysis | The aim of this phase is produce a draft version of the questionnaire. Approximately 90 patients or caregivers will be recruited in this phase for item ranking and analysis through questionnaire evaluation and cognitive interviews. | ||
| Phase 3: Instrument refinement and internal validation | The aim of this phase is generate the final version of the instrument. Approximately 101 patients or caregivers will participate in this phase by completing the questionnaire | ||
| Phase 4: External validation | In this phase the questionnaire will undergo further psychometric testing for validation and approximately 220 patients or caregivers will be asked to complete the PROFTC-I questionnaire along with quality of life instruments |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Validation of Patient reported outcome financial toxicity of cancer Italian(PROFTC-I) questionnaire | During the development of the questionnaire, individual items (questions), response options, and type of scoring will be determined according to Phases 1-3. Subsequently a principal components analysis (explorative factor analysis) will be done with eigen value set at 1; internal reliability will be assessed by inter-item correlations and Cronbach's alpha ( minimum acceptable 0.70); intraclass correlation coefficient (minimum acceptable 0.80). Correlation of final instrument with the EORTC quality of life questionnaire (criterion validity) will be assessed with using Pearson correlation coefficient. | 48 months |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients with any type of solid cancer or haematological malignancy who has undergone medical treatment, including chemotherapy, target agents, immunotherapy, hormonal treatment, radiotherapy and combinations of such therapies, or their caregivers, will be recruited in northern, central and southern Italian hospitals..
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Francesco Perrone | Contact | 0815903571 | f.perrone@istitutotumori.na.it | |
| Jane Bryce | Contact | 0815903571 | j.bryce@istitutotumori.na.it |
| Name | Affiliation | Role |
|---|---|---|
| Francesco Perrone | Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale | Principal Investigator |
| Jane Bryce | Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Azienda dei Colli | Recruiting | Naples | Italy | |||
| Istituto Nazionale Tumori, IRCCS Fondazione Pascale |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 34670762 | Derived | Riva S, Arenare L, Di Maio M, Efficace F, Montesarchio V, Frontini L, Giannarelli D, Bryce J, Del Campo L, De Lorenzo F, Iannelli E, Traclo F, Gitto L, Jommi C, Vaccaro CM, Barberio D, Cinieri S, Porta C, Del Mastro L, Zagonel V, Cogoni AA, Bordonaro R, Gimigliano A, Piccirillo MC, Guizzaro L, Gallo C, Perrone F. Cross-sectional study to develop and describe psychometric characteristics of a patient-reported instrument (PROFFIT) for measuring financial toxicity of cancer within a public healthcare system. BMJ Open. 2021 Oct 20;11(10):e049128. doi: 10.1136/bmjopen-2021-049128. | |
| 33094357 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D009369 | Neoplasms |
| D000086522 | Financial Stress |
| ID | Term |
|---|---|
| D013315 | Stress, Psychological |
| D001526 | Behavioral Symptoms |
| D001519 | Behavior |
Not provided
Not provided
Not provided
Not provided
Not provided
| Ciro Gallo | University of Campania Luigi Vanvitelli | Principal Investigator |
| Silvia Riva | St. Mary University, Twickenham, London, GB | Principal Investigator |
| Fabio Efficace | Northwestern University, Feinberg School of Medicine, GIMEMA,EORTC Quality of Life Group - Rappresentante GIMEMA | Principal Investigator |
| Francesco De Lorenzo | AIMAC and European Cancer Patient Coalition | Principal Investigator |
| Elisabetta Iannelli | Segretario Generale FAVO | Principal Investigator |
| Laura Del Campo | FAVO | Principal Investigator |
| Francesca Traclò | AIMAC | Principal Investigator |
| Massimo Di Maio | AO Ordine Mauriziano | Principal Investigator |
| Luciano Frontini | Federation of Italian Cooperative Oncology Groups | Principal Investigator |
| Vincenzo Montesarchio | Oncologia, Azienda dei Colli, Napoli - CIPOMO | Principal Investigator |
| Lara Gitto | Centro per gli Studi Economici e Internazionali - Economic Evaluation & Health Technology Assessment (CEIS EEHTA), UniversitĂ di Roma "Tor Vergata" | Principal Investigator |
| Claudio Jommi | Dipartimento di Scienze del Farmaco, UniversitĂ del Piemonte Orientale; Osservatorio Farmaci, Cergas, SDA Bocconi | Principal Investigator |
| Concetta Maria Vaccaro | Welfare e Salute CENSIS (Centro Studi Investimenti Sociali), Roma | Principal Investigator |
| Recruiting |
| Naples |
| Italy |
| Istituto Nazionale Tumori Regina Elena - IRCCS - IFO | Recruiting | Roma | Italy |
| Policlinico Universitario Campus Biomedico | Not yet recruiting | Roma | Italy |
| AO Ordine Mauriziano | Recruiting | Torino | Italy |
| Derived |
| Riva S, Efficace F, Di Maio M, Bryce J, Del Campo L, De Lorenzo F, Frontini L, Giannarelli D, Gitto L, Iannelli E, Jommi C, Montesarchio V, Traclo F, Vaccaro CM, Arenare L, Canzanella G, Gimigliano A, Romano F, Savio A, Sparavigna L, Piccirillo MC, Guizzaro L, Gallo C, Perrone F. A qualitative analysis and development of a conceptual model assessing financial toxicity in cancer patients accessing the universal healthcare system. Support Care Cancer. 2021 Jun;29(6):3219-3233. doi: 10.1007/s00520-020-05840-z. Epub 2020 Oct 22. |
| 31501130 | Derived | Riva S, Bryce J, De Lorenzo F, Del Campo L, Di Maio M, Efficace F, Frontini L, Giannarelli D, Gitto L, Iannelli E, Jommi C, Montesarchio V, Traclo F, Vaccaro CM, Gallo C, Perrone F. Development and validation of a patient-reported outcome tool to assess cancer-related financial toxicity in Italy: a protocol. BMJ Open. 2019 Sep 9;9(9):e031485. doi: 10.1136/bmjopen-2019-031485. |